Pfizer Accused Of Manipulating Epilepsy Drug Data

Law360, New York (October 8, 2008, 12:00 AM EDT) -- Plaintiffs seeking class action status in a multidistrict litigation against Pfizer Inc. have submitted documents allegedly showing that the drug giant's employees suppressed negative information about the epilepsy drug Neurontin.

The documents, which included excepts of internal Pfizer employee e-mails, were filed in the U.S. District Court for the District of Massachusetts on Monday.

Thomas M. Greene, a Boston attorney representing plaintiffs in the case, said that the documents should help plaintiffs achieve class action status.

“They document Pfizer’s scientific misconduct and unethical behavior, which caused...
To view the full article, register now.



Case Information

Case Title

Harden Manufacturing Corporation v. Pfizer, Inc. et al

Case Number




Nature of Suit

Other Statutory Actions


Patti B. Saris

Date Filed

May 14, 2004


Government Agencies

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.